Retatrutide, from Soma Pharmaceuticals , is gaining considerable attention as a novel method for obesity regulation. This unique compound combines the mechanism of a GLP-1 receptor stimulant and a GIP receptor activator , intended to not only promote weight loss but also improve underlying metabo